首页> 外文期刊>Cukurova Medical Journal >Levetiracetam and Valproic Acid: Effects on the Liver Functions and Ammonia Level in Children
【24h】

Levetiracetam and Valproic Acid: Effects on the Liver Functions and Ammonia Level in Children

机译:左乙拉西坦和丙戊酸:对儿童肝功能和氨水平的影响

获取原文
           

摘要

Purpose: There is evidence that levetiracetam and valproic acid causes a changes of serum ammonia level and liver function tests. The aim of this study was to evaluate the liver function parameters and ammonia level in children with seizures on treatment with levetiracetam in comparison treated with valproic acid. Mater?als and Methods: Between March 2010 and October 2010, we treated 42 patients with epilepsy. We determined the serum concentration of antiepileptic drug, transaminases, g-glutamyl transferase, and ammonia level in 22 children treated with valproic acid, and in 20 children treated with levetiracetam. Results: There were no significant differences in the serum transaminases, g-glutamyl transferase between the patients treated with valproic acid, and the patients treated with levetiracetam. Hyperammonemia was detected in patients treated with valproic acid. Conclus?on: These results suggest that the treatment with levetiracetam does not alter the serum ammonia level, and liver functions.
机译:目的:有证据表明左乙拉西坦和丙戊酸引起血清氨水平和肝功能检查改变。这项研究的目的是评估左乙拉西坦治疗癫痫发作儿童的肝功能参数和氨水平,与丙戊酸治疗相比。材料与方法:从2010年3月至2010年10月,我们治疗了42例癫痫患者。我们确定了22例丙戊酸治疗的儿童和20例左乙拉西坦治疗的儿童的抗癫痫药,转氨酶,g-谷氨酰转移酶和氨水平的血清浓度。结果:丙戊酸治疗的患者和左乙拉西坦治疗的患者的血清转氨酶,g-谷氨酰转移酶无明显差异。在丙戊酸治疗的患者中发现高氨血症。结论:这些结果表明用左乙拉西坦治疗不会改变血清氨水平和肝功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号